253 related articles for article (PubMed ID: 6433106)
1. Thymic epithelial antigen, acquired during ontogeny and defined by the anti-p19 monoclonal antibody, is lost in thymomas.
Savino W; Berrih S; Dardenne M
Lab Invest; 1984 Sep; 51(3):292-6. PubMed ID: 6433106
[TBL] [Abstract][Full Text] [Related]
2. Immunodetection of the thymic epithelial P19 antigen in cultures of normal and pathological human thymic epithelium.
Cohen-Kaminsky S; Berrih-Aknin S; Savino W; Dardenne M
Thymus; 1987; 9(4):225-38. PubMed ID: 3313829
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence for the expression of the carcinoembryonic antigen by human thymic epithelial cells in vitro and in neoplastic conditions.
Savino W; Durand D; Dardenne M
Am J Pathol; 1985 Dec; 121(3):418-25. PubMed ID: 3907364
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium.
Takahashi T; Ueda R; Nishida K; Namikawa R; Fukami H; Matsuyama M; Masaoka A; Imaizumi M; Takahashi T
Cancer Res; 1988 Apr; 48(7):1896-903. PubMed ID: 2450640
[TBL] [Abstract][Full Text] [Related]
6. Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody.
Dardenne M; Savino W; Bach JF
Am J Pathol; 1987 Jan; 126(1):194-8. PubMed ID: 2433946
[TBL] [Abstract][Full Text] [Related]
7. Cortical thymocyte differentiation in thymomas: an immunohistologic analysis of the pathologic microenvironment.
Takacs L; Savino W; Monostori E; Ando I; Bach JF; Dardenne M
J Immunol; 1987 Feb; 138(3):687-98. PubMed ID: 2433328
[TBL] [Abstract][Full Text] [Related]
8. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.
Savino W; Manganella G; Verley JM; Wolff A; Berrih S; Levasseur P; Binet JP; Dardenne M; Bach JF
J Clin Invest; 1985 Sep; 76(3):1140-6. PubMed ID: 2413072
[TBL] [Abstract][Full Text] [Related]
9. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Bcl-2 protein in the myasthenic thymus.
Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny.
Haynes BF; Robert-Guroff M; Metzgar RS; Franchini G; Kalyanaraman VS; Palker TJ; Gallo RC
J Exp Med; 1983 Mar; 157(3):907-20. PubMed ID: 6833950
[TBL] [Abstract][Full Text] [Related]
12. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of carcinoembryonic antigens and non cross-reacting antigens in the human thymus. Analysis on frozen sections and cultured epithelial cells using monoclonal antibodies.
Aubry J; Cohen-Kaminsky S; Berrih-Aknin S
Thymus; 1990 Mar; 15(2):107-23. PubMed ID: 2185585
[TBL] [Abstract][Full Text] [Related]
14. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic changes of the subseptal thymic epithelium in myasthenia gravis.
Savino W; Takacs L; Monostori E; Dardenne M
Thymus; 1988-1989; 12(2):111-6. PubMed ID: 2471300
[TBL] [Abstract][Full Text] [Related]
16. Pathological aspects of malignant and benign thymic disorders.
Müller-Hermelink HK; Marx A
Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
[TBL] [Abstract][Full Text] [Related]
17. The thymus in myasthenia gravis. Evidence for altered cell populations.
Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
[No Abstract] [Full Text] [Related]
18. Myoid cells and neuroendocrine markers in myasthenic thymuses.
Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W
Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
20. Human T cell antigen expression during the early stages of fetal thymic maturation.
Lobach DF; Hensley LL; Ho W; Haynes BF
J Immunol; 1985 Sep; 135(3):1752-9. PubMed ID: 3926883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]